Pages that link to "Q44577649"
Jump to navigation
Jump to search
The following pages link to Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats (Q44577649):
Displaying 25 items.
- SLE-associated risk factors affect DC function (Q26774797) (← links)
- Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS? (Q26774826) (← links)
- Regulatory dendritic cells for immunotherapy in immunologic diseases (Q26866216) (← links)
- Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE). (Q31044261) (← links)
- Immune regulation by B cells and antibodies a view towards the clinic. (Q33381036) (← links)
- Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation (Q33650505) (← links)
- A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC (Q33694528) (← links)
- Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis. (Q34175672) (← links)
- Designer dendritic cells for tolerance induction: guided not misguided missiles (Q34319943) (← links)
- Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses (Q34580296) (← links)
- Role of surfactant protein A in the innate host defense and autoimmunity (Q35855829) (← links)
- Antigen-specific therapies in multiple sclerosis. (Q36327373) (← links)
- Immunomodulatory strategies for celiac disease (Q36327386) (← links)
- Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases (Q36976323) (← links)
- Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity. (Q37344594) (← links)
- Development of dendritic cell-based immunotherapy for autoimmunity (Q37701864) (← links)
- Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells (Q42797969) (← links)
- Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis (Q43904319) (← links)
- Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells (Q44546775) (← links)
- Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis. (Q45340759) (← links)
- Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo (Q45880924) (← links)
- Autoantigen-pulsed dendritic cells constitute a beneficial cytokine and growth factor network in ameliorating experimental allergic encephalomyelitis. (Q53664851) (← links)
- Tolerising cellular therapies: what is their promise for autoimmune disease? (Q58615311) (← links)
- Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats (Q74445974) (← links)
- Dendritic Cells As Inducers of Peripheral Tolerance (Q88820708) (← links)